Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Change in Receivables (2024 - 2025)

Invivyd's (IVVD) quarterly Change in Receivables came in at $4.1 million in Q4 2025, up 47.82% on a YoY basis from $2.8 million in Q4 2024, and up 199.12% quarter-over-quarter from $1.4 million in Q3 2025.

Analysis

Invivyd (IVVD) Change in Receivables (2024 - 2025) Analysis & Trends

Invivyd (IVVD) has reported Change in Receivables for 2 consecutive years, with $4.1 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables rose 47.82% year-over-year to $4.1 million; the trailing twelve-month figure through Dec 2025 stood at $3.3 million (down 69.4% YoY), and the FY2025 full-year result was $3.3 million, down 69.4% from the prior year.
  • Change in Receivables improved to $4.1 million in Q4 2025 per IVVD's latest filing, from $1.4 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $5.3 million in Q3 2024 and bottomed at -$2.3 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 1.09 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 333.00 Mn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 140.20 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 838.50 Mn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -53.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 31.60 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 269.40 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 37.16 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.07 Mn
Sep 30, 2025 1.36 Mn
Jun 30, 2025 254,000.00
Mar 31, 2025 -2.35 Mn
Dec 31, 2024 2.75 Mn
Sep 30, 2024 5.27 Mn
Jun 30, 2024 2.89 Mn